Clinical Trial Update: A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC [Phase 1]

View source ↗

Summary

Phase 1 study evaluating dasatinib, cetuximab, and radiation with or without cisplatin in head and neck cancer; trial terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DASATINIB (Dasatinib)
• radiation

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Head and Neck Cancer | Phase 1 | Status: TERMINATED | Results posted: 2017-02-23